MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+21.73%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$351M
AUM Growth
+$351M
(-15%)
Cap. Flow
-$8.44M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
ProShares UltraShort S&P500
SDS
|
$3.39M |
| 2 |
ProShares UltraPro Short S&P 500
SPXU
|
$2.73M |
| 3 |
ProShares UltraPro Short QQQ
SQQQ
|
$2.32M |
Sector Composition
| 1 | Healthcare | 95.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $200M | 56.91% | 15,001,073 | – | – |
|
2
Esperion Therapeutics
ESPR
$448M
| $121M | 34.4% | 2,679,835 | – | – |
|
3
Alkermes
ALKS
$4.78B
| $13.7M | 3.92% | 892,400 | – | – |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $8.49M | 2.42% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $7.51M | 2.14% | 400,000 | – | – |
|
6
Celldex Therapeutics
CLDX
$1.47B
| $708K | 0.2% | 420,846 | – | – |
|
|
7
ProShares UltraShort S&P500
SDS
$445M
| – | – | -115,000 | Closed | -$3.39M |
|
|
8
ProShares UltraPro Short S&P 500
SPXU
$527M
| – | – | -105,000 | Closed | -$2.73M |
|
|
9
ProShares UltraPro Short QQQ
SQQQ
$2.39B
| – | – | -71,250 | Closed | -$2.32M |
|